pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CTx-001 · news · pharmadog
← back to CTx-001
News mentioning CTx-001
19
stories
1d
AstraZeneca, Calidi, Tempest make significant workforce cuts
biospace
1d
Vertex on the verge of ‘iconic’ evolution as key kidney disease verdict looms
biospace
1d
Genetix’s genetic medicines are officially profitable, with $327M in sales YTD
biospace
1d
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
biospace
1d
Marrow sets out to challenge genetic medicines for severe blood diseases
biopharma dive
5d
Marrow extracts $120M series B to advance preclinical blood disease therapy
fiercebiotech
8d
Beam’s base editing therapy for sickle cell hits goal in pivotal trial
biopharma dive
8d
Beam’s sickle cell therapy results tee up potential Casgevy, Lyfgenia showdown
fiercebiotech
15d
Vertex, ahead of FDA decision, calms fears surrounding kidney drug
biopharma dive
16d
Plug-and-play gene therapy: FDA executes on vision that’s been in the works for years
biospace
21d
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
biospace
29d
Most new drugs are still too costly at launch, ICER says
biopharma dive
Jul 13, 26
Biotech startup funding gap widens despite rebound in VC investment
biopharma dive
Jul 2, 26
Vertex's sickle cell therapy approved for kids; United Therapeutics buys startup
endpoints
Jul 1, 26
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
fda press
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
May 5, 26
Vertex earnings get muted investor response
biopharma dive
Apr 27, 26
STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more
stat
Apr 27, 26
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
stat